Measles Resurgence in US: A Grim Warning for Public Health

The steady climb of measles cases across the United States is more than a public health concern; it’s a signal, experts say, of deeper vulnerabilities in the nation’s ability to respond to infectious disease threats. After decades of relative rarity – between 1993 and 2024, cases typically numbered in the hundreds annually – measles is firmly re-established in American communities, and the trend is accelerating.

As of March 5, 2026, the Centers for Disease Control and Prevention (CDC) has confirmed 1,281 measles cases in the U.S. This year, with cases reported in 31 states. This figure already surpasses totals from recent years, and health officials anticipate exceeding the 2,283 cases reported in 2025 – the highest number in 35 years. Four cases have been identified in international visitors.

A Multi-State Pattern of Outbreaks

The resurgence isn’t isolated to a single location. Measles outbreaks are actively circulating in multiple states. The outbreak in Texas, which began in January 2025 and lasted through August, was followed by ongoing cases on the Utah and Arizona border starting in August. A separate outbreak in South Carolina, which began in September 2025, saw a dramatic increase in January 2026 and continues to spread. These outbreaks are not occurring in isolation; thirty states have reported cases this year, and 47 have seen cases since the beginning of 2025.

The Role of Declining Vaccination Rates

At the heart of this resurgence is a decline in vaccination rates. Approximately 90% of the U.S. Population has received the MMR (measles, mumps, and rubella) vaccine. However, in some regions, that rate dips below 60%, falling short of the 95% threshold needed to achieve herd immunity. Herd immunity occurs when a large portion of a community is immune to a disease, making the spread unlikely and protecting those who cannot be vaccinated, such as infants or individuals with certain medical conditions.

The U.S. Was declared to have eliminated measles in 2000, meaning continuous transmission of the virus had stopped. However, current trends threaten that status. The Pan American Health Organization (PAHO) postponed a decision on whether to revoke the U.S.’s measles-elimination status, originally scheduled for April, until November. Mexico is also battling the disease and may lose its elimination status as well. Canada lost its measles-free status in November 2025.

Beyond Hospitalizations: The Long-Term Health Consequences

The immediate impact of measles is often most visible in hospitalizations. In 2025, three people in the U.S. Died from measles – the highest number in 25 years. Of the 2,283 confirmed cases in 2025, 11% required hospitalization. However, the consequences of measles extend far beyond acute illness.

Measles can lead to serious complications, including pneumonia and encephalitis (brain swelling), which can cause permanent disabilities like deafness or intellectual disability. More rarely, the virus can trigger subacute sclerosing panencephalitis (SSPE), a progressive and fatal dementia that can develop years after the initial infection. A school-age child in Los Angeles recently died from SSPE after being infected with measles as an infant, before vaccination was possible.

The Economic Burden of Resurgent Measles

Recurring measles outbreaks carry a significant economic cost. Containing outbreaks can cost tens of thousands of dollars per case, encompassing public health responses, medical expenses, and lost productivity. A 2018-2019 outbreak in Washington state, involving just 72 cases, cost $3.2 million. Studies suggest that a sustained 1% drop in MMR coverage could cost the U.S. Billions of dollars across healthcare systems and the broader economy.

A Warning Sign for Pandemic Preparedness

Experts at Brown University’s Pandemic Center view the return of measles as a “grim signal” of broader weaknesses in the U.S.’s ability to manage infectious disease threats. The steps needed to control measles – vaccination, case detection, isolation, contact tracing, and treatment – are the same steps required to manage other infectious diseases, including novel pathogens.

Declining vaccination rates and eroding public trust in public health institutions raise concerns about the nation’s overall preparedness. Recent polling data indicates that less than half of Americans have a high level of trust in the CDC to provide reliable vaccine information. This erosion of trust complicates efforts to protect the population from future outbreaks and pandemics.

Looking Ahead: Surveillance and Public Health Response

The CDC continues to monitor measles cases and outbreaks closely, providing guidance to state and local health departments. Maintaining robust surveillance systems is crucial for detecting and responding to outbreaks quickly. Efforts to improve vaccination rates and rebuild public trust in vaccines are also essential. The PAHO will revisit the U.S.’s measles elimination status in November, and ongoing monitoring will determine whether the country can regain its status. The situation in Mexico will also be closely watched, as outbreaks in neighboring countries can impact transmission patterns.